Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
HIV Medicine|April 28, 2025
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohortAndrea De Vito, Alessandro Tavelli, Alessandro Cozzi-Lepri, et al.Sexually Transmitted Infections|March 24, 2026
Medical and psychological needs for injectable long-acting cabotegravir as pre-exposure prophylaxisRoberto Rossotti, Alessandra Bianchi, Alessandro Tavelli, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohortsRoberto Rossotti, Alessandro Tavelli, Stefano Bonora, et al.Sexually Transmitted Diseases|November 4, 2025
Patterns and correlates of initiation of long-acting injectable cabotegravir for pre-exposure prophylaxis: a case-control analysisRoberto Rossotti, Gabriele Cavazza, Enrico Caruso, et al.International Journal of STD & AIDS|November 23, 2025
Two-drugs regimens did not influence total HIV-1 DNA in people living with HIVGabriele Cavazza, Alice Nava, Elena Nicolini, et al.Sexually Transmitted Diseases|May 9, 2025
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis ServiceRoberto Rossotti, Enrico Caruso, Daniele Calzavara, et al.Scandinavian Journal of Infectious Diseases|July 19, 2012
Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: a case-control studyRoberto Rossotti, Maria Cristina Moioli, Leonardo Chianura, et al.HIV Medicine|February 23, 2026
Achieving reimbursable PrEP is insufficient to increase and diversify the users attending community-based servicesEnrico Caruso, Alessandro Tavelli, Anna De Bona, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2022
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantationRoberto Rossotti, Marco Merli, Chiara Mazzarelli, et al.Journal of Viral Hepatitis|February 26, 2019
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 periodAndrea Lombardi, Roberto Rossotti, Maria Cristina Moioli, et al.Pageof 6